Currently, commonly used PD-L1 evaluation systems include tumor cell positive proportion score (i.e. tumor proportion score, TPS), combined positive score (CPS), and immune cell positive proportion score (IPS, IC score, etc.). This evidence concerns the gene CD274 and neoplasm.